Kymera Therapeutics, Inc. (KYMR): 3 insider purchases in the last two years.
| Filed | Insider | Shares | Price | Value | Type |
|---|---|---|---|---|---|
| Dec 11, 2025 | Baker Felix Director, TenPercentOwner | 2,005,813 | $86.00 | $172.5M | no history |
| Jul 1, 2025 | Biotechnology Value Trading Fund OS LP Director, Other | 317,167 | $44.00 | $14.0M | no history |
| Jun 30, 2025 | Baker Bros. Advisors (GP) LLC Director | 655,500 | $44.00 | $28.8M | no history |
Open-market purchases from SEC Form 4. "Opportunistic" = this insider trades every year but not on a fixed schedule (Cohen, Malloy & Pomorski); "routine" buys carry little information.
Free account. Know when insiders, famous funds or Congress trade it.